The Leadership Team at Dopavision is responsible for guiding the strategic direction and overall vision of the company as it develops novel therapies for myopia in children and adolescents. This diverse group of executives—including the CEO, CTO, and Chief Medical Officer—collaborates to oversee research and development, ensure regulatory compliance, and secure funding for innovative initiatives, all while fostering partnerships with key stakeholders in healthcare and technology to bring their breakthrough solutions to market.
View all